King's College Hospital used the workforce capacity modelling tool developed by the Health Innovation Network (HIN) South London to plan the implementation of the NICE technology appraisal guidance on ...
This new study from Canada compared outcomes in patients living with type 1 diabetes who used 2 closed-loop insulin delivery systems: a fully artificial pancreas that did not require meal input and a ...
Pediatric and adult Type 1 diabetes patients receiving a hybrid closed-loop artificial pancreas therapy demonstrated improved glucose control and lower risk of hypoglycemia compared to those managing ...
Please provide your email address to receive an email when new articles are posted on . Pregnant women with type 1 diabetes had a lower time below range with the MiniMed 780 system vs. standard of ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Use of the CamAPS FX hybrid closed-loop system improved ...
People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With open-loop therapies, insulin administration is manually controlled, while hybrid ...
The National Institute for Health and Care Excellence (NICE), England’s cost-effectiveness watchdog, has finalized a draft guidance regarding hybrid closed-loop systems, concluding that the technology ...
Young children using the t:slim X2 insulin pump with Control-IQ Technology system maintained target glucose levels for 3 hours longer than children using an insulin pump or daily injections with a ...
HAMBURG, Germany -- A hybrid closed-loop insulin therapy system significantly improved glycemic control among pregnant women with type 1 diabetes, the randomized AiDAPT trial showed. Meeting the ...
Closed-loop insulin delivery systems, designed to automate aspects of diabetes management in children and teenagers, yielded significantly higher blood glucose time in range for children with type 1 ...
Closed-loop control systems of insulin delivery may improve glycemic outcomes in young children with type 1 diabetes. The efficacy and safety of initiating a closed-loop system virtually are unclear.
People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With open-loop therapies*, insulin administration is manually controlled, while hybrid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results